SCHEMBL6100284

SCHEMBL6100284

O=C(O)CC1CN(CC(=O)O)CCN1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC2 Q13490 1/20 0.41
MAPT P10636 1/20 0.38
HSD17B10 Q99714 2/20 0.36
ITGB3 P05106 1/20 0.36
ITGB2 P05107 1/20 0.36
ITGB1 P05556 1/20 0.36
ITGAV P06756 1/20 0.36
ITGA2B P08514 1/20 0.36
ITGA5 P08648 1/20 0.36
ITGB5 P18084 1/20 0.36
ITGAL P20701 1/20 0.36
GRIN2D O15399 2/20 0.35
GRIN3B O60391 2/20 0.35
THRB P10828 2/20 0.35
GRIN1 Q05586 2/20 0.35
GRIN2A Q12879 2/20 0.35
GRIN2B Q13224 2/20 0.35
GRIN2C Q14957 2/20 0.35
GRIN3A Q8TCU5 2/20 0.35
ALOX15 P16050 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8815561 0.97 BIRC2 (0.40) BIRC2MAPTHSD17B10ITGB3ITGB2
SCHEMBL15894887 0.89 BIRC2 (0.38) BIRC2MAPTHSD17B10ITGB3ITGB2
SCHEMBL24296905 0.86 BIRC2 (0.36) BIRC2MAPTHSD17B10
SCHEMBL14097349 0.86 BIRC2 (0.41) BIRC2MAPTHSD17B10GRIN2DGRIN3B
SCHEMBL6865237 0.85 HSD17B10 (0.35) BIRC2HSD17B10ITGB3ITGB2ITGB1
SCHEMBL31679369 0.83 CXCR4 (0.42) BIRC2HSD17B10ITGB3ITGB2ITGB1
SCHEMBL9187015 0.83 BIRC2 (0.40) BIRC2MAPTHSD17B10GRIN2DGRIN3B
SCHEMBL2628596 0.81 BIRC2 (0.36) BIRC2MAPTHSD17B10GRIN2DGRIN3B
SCHEMBL1468944 0.79 BIRC2 (0.35) BIRC2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4960304 0.79 BIRC2 (0.35) BIRC2MAPTITGB3ITGB2ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9668973-B2 Components for producing amphoteric liposomes MARINA BIOTECH, INC. (US) 2017-06-06 US disclosed
US-20140227345-A1 COMPONENTS FOR PRODUCING AMPHOTERIC LIPOSOMES MARINA BIOTECH, INC. (US) 2014-08-14 US disclosed
US-7109326-B2 Halo-alkoxycarbonyl prodrugs GENENTECH, INC. (US) 2006-09-19 US disclosed
EP-0975608-B1 HALO-ALKOXYCARBONYL PRODRUGS GENENTECH INC (US) 2005-06-15 EP disclosed
US-20040220401-A1 Novel halo-alkoxycarbonyl prodrugs GENENTECH, INC. 2004-11-04 US disclosed
US-20010020019-A1 NOVEL HALO-ALKOXYCARBONYL PRODRUGS GENENTECH, INC. 2001-09-06 US disclosed
EP-0975608-A2 HALO-ALKOXYCARBONYL PRODRUGS Genentech, Inc. (US) 2000-02-02 EP disclosed
WO-1998046576-A2 HALO-ALKOXYCARBONYL PRODRUGS GENENTECH, INC. (US) 1998-10-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040220401-A1 Novel halo-alkoxycarbonyl prodrugs PNP, PAICS, PHOSPHO1 BIRC2 3234/4885MAPT 2386/4885HSD17B10 1050/4885
US-20140227345-A1 COMPONENTS FOR PRODUCING AMPHOTERIC LIPOSOMES PHOSPHO1, SGMS1, CHMP4B BIRC2 357/4885MAPT 3179/4885HSD17B10 3084/4885
US-20010020019-A1 NOVEL HALO-ALKOXYCARBONYL PRODRUGS PNP, PAICS, PHOSPHO1 BIRC2 3234/4885MAPT 2386/4885HSD17B10 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.